Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bei Chen

Showing results (591-600 of 633) with videos related to

Pageof 64
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2019
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical managementSounak Gupta, John C Cheville, Achim A Jungbluth, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 2025
TRIM63 Overexpression in FISH-Negative MiTF Family Altered Renal Cell Carcinoma (MiTF RCC)Rahul Mannan, Ying-Bei Chen, Xiaoming Wang, et al.
Blood|March 24, 2020
SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDSBing-Yi Chen, Junhong Song, Cheng-Long Hu, et al.
Genome Research|July 29, 2011
Dynamics of the epigenetic landscape during erythroid differentiation after GATA1 restorationWeisheng Wu, Yong Cheng, Cheryl A Keller, et al.
Emerging Microbes & Infections|April 29, 2020
Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patientJing Sun, Airu Zhu, Heying Li, et al.
Nature Communications|October 8, 2016
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsetsYing-Bei Chen, Jianing Xu, Anders Jacobsen Skanderup, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2024
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic ImplicationsDilara Akbulut, Karissa Whiting, Min-Yuen Teo, et al.
European Urology|October 19, 2016
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell CarcinomaJames J Hsieh, David Chen, Patricia I Wang, et al.
European Urology|November 5, 2025
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell CarcinomaMark T Dawidek, Lina Posada Calderon, Parantu K Shah, et al.
European Urology Focus|July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy SamplesYiyu Dong, Brandon J Manley, Maria F Becerra, et al.
Pageof 64

Showing results (591-600 of 633) with videos related to

Sort By:
Pageof 64
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2019
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical managementSounak Gupta, John C Cheville, Achim A Jungbluth, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 2025
TRIM63 Overexpression in FISH-Negative MiTF Family Altered Renal Cell Carcinoma (MiTF RCC)Rahul Mannan, Ying-Bei Chen, Xiaoming Wang, et al.
Blood|March 24, 2020
SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDSBing-Yi Chen, Junhong Song, Cheng-Long Hu, et al.
Genome Research|July 29, 2011
Dynamics of the epigenetic landscape during erythroid differentiation after GATA1 restorationWeisheng Wu, Yong Cheng, Cheryl A Keller, et al.
Emerging Microbes & Infections|April 29, 2020
Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patientJing Sun, Airu Zhu, Heying Li, et al.
Nature Communications|October 8, 2016
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsetsYing-Bei Chen, Jianing Xu, Anders Jacobsen Skanderup, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2024
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic ImplicationsDilara Akbulut, Karissa Whiting, Min-Yuen Teo, et al.
European Urology|October 19, 2016
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell CarcinomaJames J Hsieh, David Chen, Patricia I Wang, et al.
European Urology|November 5, 2025
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell CarcinomaMark T Dawidek, Lina Posada Calderon, Parantu K Shah, et al.
European Urology Focus|July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy SamplesYiyu Dong, Brandon J Manley, Maria F Becerra, et al.
Pageof 64